Infectious pathogens and risk of esophageal, gastric and duodenal cancers and ulcers in China: A case-cohort study.
Adult
Humans
Cohort Studies
Duodenal Ulcer
/ epidemiology
Ulcer
/ complications
Duodenal Neoplasms
Seroepidemiologic Studies
Epstein-Barr Virus Infections
/ complications
Herpesvirus 4, Human
Cardia
Gastrointestinal Neoplasms
Hepatitis C
/ complications
Helicobacter Infections
/ complications
Helicobacter pylori
duodenal cancer
duodenal ulcer
esophageal cancer
gastric cancer
infectious pathogens
Journal
International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124
Informations de publication
Date de publication:
15 Apr 2024
15 Apr 2024
Historique:
revised:
16
10
2023
received:
17
05
2023
accepted:
24
10
2023
pmc-release:
15
04
2024
medline:
13
2
2024
pubmed:
18
12
2023
entrez:
18
12
2023
Statut:
ppublish
Résumé
Infection by certain pathogens is associated with cancer development. We conducted a case-cohort study of ~2500 incident cases of esophageal, gastric and duodenal cancer, and gastric and duodenal ulcer and a randomly selected subcohort of ~2000 individuals within the China Kadoorie Biobank study of >0.5 million adults. We used a bead-based multiplex serology assay to measure antibodies against 19 pathogens (total 43 antigens) in baseline plasma samples. Associations between pathogens and antigen-specific antibodies with risks of site-specific cancers and ulcers were assessed using Cox regression fitted using the Prentice pseudo-partial likelihood. Seroprevalence varied for different pathogens, from 0.7% for Hepatitis C virus (HCV) to 99.8% for Epstein-Barr virus (EBV) in the subcohort. Compared to participants seronegative for the corresponding pathogen, Helicobacter pylori seropositivity was associated with a higher risk of non-cardia (adjusted hazard ratio [HR] 2.73 [95% CI: 2.09-3.58]) and cardia (1.67 [1.18-2.38]) gastric cancer and duodenal ulcer (2.71 [1.79-4.08]). HCV was associated with a higher risk of duodenal cancer (6.23 [1.52-25.62]) and Hepatitis B virus was associated with higher risk of duodenal ulcer (1.46 [1.04-2.05]). There were some associations of antibodies again some herpesviruses and human papillomaviruses with risks of gastrointestinal cancers and ulcers but these should be interpreted with caution. This first study of multiple pathogens with risk of gastrointestinal cancers and ulcers demonstrated that several pathogens are associated with risks of gastrointestinal cancers and ulcers. This will inform future investigations into the role of infection in the etiology of these diseases.
Identifiants
pubmed: 38108203
doi: 10.1002/ijc.34814
pmc: PMC7615747
mid: EMS194687
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1423-1432Subventions
Organisme : Cancer Research UK
ID : 24504
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CH/1996001/9454
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C500/A16896
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C16077/A29186
Pays : United Kingdom
Informations de copyright
© 2023 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.
Références
Infect Agent Cancer. 2014 Jan 20;9(1):3
pubmed: 24438207
Int J Epidemiol. 2016 Jun;45(3):774-81
pubmed: 27170766
Cancer Epidemiol. 2017 Oct;50(Pt A):76-84
pubmed: 28888185
Int J Epidemiol. 2023 Aug 2;52(4):1197-1208
pubmed: 36913255
Clin Chem. 2005 Oct;51(10):1845-53
pubmed: 16099939
Int J Epidemiol. 2011 Dec;40(6):1652-66
pubmed: 22158673
Cancer Epidemiol Biomarkers Prev. 2012 Dec;21(12):2185-92
pubmed: 23035179
Lancet Oncol. 2009 Apr;10(4):321-2
pubmed: 19350698
Cancer Res. 2015 Nov 15;75(22):4876-83
pubmed: 26383162
Lancet Glob Health. 2020 Feb;8(2):e191-e203
pubmed: 31812369
JAMA Netw Open. 2019 Jun 5;2(6):e195718
pubmed: 31199446
Lancet Glob Health. 2020 Feb;8(2):e180-e190
pubmed: 31862245
Int J Cancer. 2016 Jul 1;139(1):85-98
pubmed: 26529033
BMJ Open. 2022 May 9;12(5):e058353
pubmed: 35534062
Front Cell Infect Microbiol. 2022 May 03;12:894836
pubmed: 35592651
Cancer Res Treat. 2005 Dec;37(6):319-24
pubmed: 19956366
J Glob Infect Dis. 2009 Jan;1(1):33-7
pubmed: 20300384
Int J Epidemiol. 2006 Jun;35(3):741-8
pubmed: 16144861
BMC Med Res Methodol. 2013 Jul 09;13:88
pubmed: 23834739
Br J Cancer. 2015 Mar 31;112(7):1283-90
pubmed: 25695484
Lancet Public Health. 2021 Dec;6(12):e888-e896
pubmed: 34838195
PLoS One. 2016 Jul 13;11(7):e0159140
pubmed: 27409078
Front Microbiol. 2015 May 11;6:412
pubmed: 26029176
Int J Cancer. 2015 Oct 15;137(8):1938-46
pubmed: 25845708
Int J Cancer. 2006 Aug 1;119(3):579-84
pubmed: 16496409
Sci Rep. 2019 Dec 19;9(1):19444
pubmed: 31857595
Int J Cancer. 2015 Jan 15;136(2):487-90
pubmed: 24889903
Int J Cancer. 2020 Dec 1;147(11):3075-3084
pubmed: 32478856
Viruses. 2012 Dec;4(12):3420-39
pubmed: 23342366
J Virol. 1998 Feb;72(2):1131-7
pubmed: 9445009